Physician_Profile_ID,Category,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID,Total_Amount_of_Payment_USDollars,Date_of_Payment,Category,Record_ID
64654,GNRL,"Organogenesis Inc.",MA,100000011175,2750.00,05/26/2015,GNRL,283291110
64654,GNRL,"Organogenesis Inc.",MA,100000011175,2500.00,10/30/2013,GNRL,105363832
64654,GNRL,"Organogenesis Inc.",MA,100000011175,2000.00,10/25/2013,GNRL,105363760
64654,GNRL,"Organogenesis Inc.",MA,100000011175,2000.00,11/07/2013,GNRL,317546992
64654,GNRL,"Organogenesis Inc.",MA,100000011175,2000.00,01/07/2014,GNRL,222250592
64654,GNRL,"Organogenesis Inc.",MA,100000011175,2000.00,02/25/2014,GNRL,222250594
64654,GNRL,"Organogenesis Inc.",MA,100000011175,1750.00,08/21/2013,GNRL,105363700
64654,GNRL,"Organogenesis Inc.",MA,100000011175,1500.00,12/16/2014,GNRL,222250598
64654,GNRL,"Organogenesis Inc.",MA,100000011175,1250.00,09/16/2013,GNRL,105363674
64654,GNRL,"Organogenesis Inc.",MA,100000011175,1000.00,10/29/2013,GNRL,105363632
64654,GNRL,"Organogenesis Inc.",MA,100000011175,1000.00,10/25/2013,GNRL,105363630
64654,GNRL,"LifeCell Corporation",NJ,100000010566,948.14,11/08/2013,GNRL,178711950
64654,GNRL,"Organogenesis Inc.",MA,100000011175,750.00,01/07/2014,GNRL,222250600
64654,GNRL,"LifeCell Corporation",NJ,100000010566,630.54,11/08/2013,GNRL,178711952
64654,GNRL,"Organogenesis Inc.",MA,100000011175,594.65,09/09/2013,GNRL,105408182
64654,GNRL,"Covidien Sales LLC",MA,100000000098,572.00,05/05/2014,GNRL,222076532
64654,GNRL,"KCI USA, Inc",TX,100000010396,525.70,09/30/2014,GNRL,198888994
64654,GNRL,"Cook Incorporated",IN,100000010458,432.00,07/07/2014,GNRL,211328772
64654,GNRL,"AngioDynamics, Inc.",NY,100000005504,391.80,09/25/2013,GNRL,31850923
64654,GNRL,"Organogenesis Inc.",MA,100000011175,351.30,06/16/2015,GNRL,283291118
64654,GNRL,"KCI USA, Inc",TX,100000010396,230.57,11/07/2014,GNRL,198883358
64654,GNRL,"Covidien Sales LLC",MA,100000000098,194.35,05/20/2014,GNRL,222076528
64654,GNRL,"LifeCell Corporation",NJ,100000010566,156.01,09/26/2013,GNRL,178712956
64654,GNRL,"Organogenesis Inc.",MA,100000011175,152.65,11/30/2013,GNRL,105408290
64654,GNRL,"Organogenesis Inc.",MA,100000011175,152.65,11/30/2013,GNRL,105408296
64654,GNRL,"Organogenesis Inc.",MA,100000011175,152.64,11/30/2013,GNRL,105408294
64654,GNRL,"Organogenesis Inc.",MA,100000011175,152.64,11/30/2013,GNRL,105408292
64654,GNRL,"LifeCell Corporation",NJ,100000010566,150.00,11/08/2013,GNRL,178713986
64654,GNRL,"LifeCell Corporation",NJ,100000010566,145.19,11/09/2013,GNRL,178709808
64654,GNRL,"Organogenesis Inc.",MA,100000011175,143.19,05/14/2015,GNRL,283291114
64654,GNRL,"Bard Peripheral Vascular, Inc.",AZ,100000005481,140.57,08/19/2015,GNRL,317656110
64654,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,137.61,10/23/2014,GNRL,193439894
64654,GNRL,"LifeCell Corporation",NJ,100000010566,136.32,10/28/2014,GNRL,188356944
64654,GNRL,"LifeCell Corporation",NJ,100000010566,133.94,01/29/2014,GNRL,188324182
64654,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,132.37,11/12/2013,GNRL,100728630
64654,GNRL,"LifeCell Corporation",NJ,100000010566,131.48,11/14/2013,GNRL,178711354
64654,GNRL,"Pfizer Inc.",NY,100000000286,131.10,01/30/2015,GNRL,323112387
64654,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,125.00,02/02/2015,GNRL,256264600
64654,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,125.00,06/24/2015,GNRL,332434721
64654,GNRL,"Smith & Nephew, Inc.",TN,100000005456,122.58,03/09/2015,GNRL,303082378
64654,GNRL,"Organogenesis Inc.",MA,100000011175,119.52,10/24/2013,GNRL,105408028
64654,GNRL,"Actelion Pharmaceuticals US, Inc.",CA,100000010813,119.08,07/15/2015,GNRL,326574050
64654,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,119.05,07/07/2015,GNRL,318816125
64654,GNRL,"Organogenesis Inc.",MA,100000011175,117.75,08/15/2013,GNRL,105408012
64654,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,115.00,04/22/2014,GNRL,155747600
64654,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,114.78,04/02/2015,GNRL,332378171
64654,GNRL,"Gilead Sciences Inc",CA,100000000108,113.14,12/22/2014,GNRL,168246618
64654,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,112.17,10/16/2013,GNRL,103228054
64654,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,111.85,09/09/2014,GNRL,148687088
64654,GNRL,"Genentech USA, Inc.",CA,100000000226,111.53,09/18/2013,GNRL,29796004
64654,GNRL,"ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)",PA,100000000178,110.72,05/28/2015,GNRL,252559522
64654,GNRL,"Celgene Corporation",NJ,100000000343,109.77,07/09/2015,GNRL,328272442
64654,GNRL,"Amgen Inc.",CA,100000000203,108.11,09/10/2015,GNRL,297198544
64654,GNRL,"Gilead Sciences Inc",CA,100000000108,106.26,05/21/2015,GNRL,316597230
64654,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,105.77,11/18/2014,GNRL,150741770
64654,GNRL,"Medtronic Sofamor Danek USA, Inc.",MN,100000010386,105.57,09/18/2013,GNRL,12876358
64654,GNRL,"Pfizer Inc.",NY,100000000286,105.38,04/17/2014,GNRL,207348240
64654,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,105.00,08/31/2015,GNRL,290539146
64654,GNRL,"Eisai Inc.",NJ,100000000136,104.17,02/25/2014,GNRL,184558748
64654,GNRL,"Astellas Pharma US Inc",IL,100000000137,103.46,10/17/2013,GNRL,111744702
64654,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,103.41,11/04/2014,GNRL,148738292
64654,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,102.48,03/05/2015,GNRL,332332965
64654,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,102.42,02/11/2015,GNRL,325857756
64654,GNRL,"St. Jude Medical, Inc.",MN,100000000310,102.08,06/17/2015,GNRL,259477004
64654,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,100.64,05/20/2014,GNRL,150153358
64654,GNRL,"Biocompatibles, Inc.",CT,100000011081,100.44,04/21/2014,GNRL,220825682
64654,GNRL,"Covidien Sales LLC",MA,100000000098,100.00,08/26/2014,GNRL,222076526
64654,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,100.00,03/10/2015,GNRL,274767856
64654,GNRL,"Cardiovascular Systems Inc.",MN,100000000117,99.79,06/12/2014,GNRL,204299282
64654,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,99.63,11/10/2014,GNRL,188143930
64654,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,99.29,09/16/2015,GNRL,331953943
64654,GNRL,"CSL Behring",PA,100000005563,98.28,11/05/2014,GNRL,217899928
64654,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,98.28,01/30/2014,GNRL,216256194
64654,GNRL,"CSL Behring",PA,100000005563,98.28,03/02/2015,GNRL,338442374
64654,GNRL,"Organogenesis Inc.",MA,100000011175,96.37,12/08/2014,GNRL,222248132
64654,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,96.24,01/22/2015,GNRL,332309365
64654,GNRL,"Pfizer Inc.",NY,100000000286,96.05,10/01/2015,GNRL,323604004
64654,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,95.15,08/24/2015,GNRL,319673531
64654,GNRL,"Pfizer Inc.",NY,100000000286,94.84,02/13/2014,GNRL,207329994
64654,GNRL,"Bayer HealthCare Pharmaceuticals Inc.",NJ,100000005467,93.20,05/12/2015,GNRL,337919652
64654,GNRL,"Pfizer Inc.",NY,100000000286,92.91,06/06/2014,GNRL,206720758
64654,GNRL,"Organogenesis Inc.",MA,100000011175,92.31,05/14/2015,GNRL,283291106
64654,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,91.01,06/17/2014,GNRL,155747598
64654,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,90.90,03/12/2014,GNRL,187800246
64654,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,90.59,08/28/2013,GNRL,23817234
64654,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,90.26,07/28/2015,GNRL,332455545
64654,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,90.09,06/10/2015,GNRL,318733390
64654,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,89.76,04/30/2015,GNRL,319061936
64654,GNRL,"Gilead Sciences Inc",CA,100000000108,89.33,06/16/2015,GNRL,316597228
64654,GNRL,"Novo Nordisk Inc",NJ,100000000144,89.21,04/03/2014,GNRL,162202210
64654,GNRL,"Pfizer Inc.",NY,100000000286,88.73,11/04/2014,GNRL,207268850
64654,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,88.32,05/05/2015,GNRL,274767852
64654,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,88.09,09/11/2014,GNRL,196390414
64654,GNRL,"Cook Incorporated",IN,100000010458,87.91,08/14/2014,GNRL,211348098
64654,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,87.80,09/16/2014,GNRL,148989610
64654,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,86.25,04/22/2014,GNRL,155747594
64654,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,84.91,07/27/2015,GNRL,332455038
64654,GNRL,"Eisai Inc.",NJ,100000000136,84.84,01/15/2014,GNRL,184558742
64654,GNRL,"TEI Medical Inc.",MA,100000071385,84.19,10/13/2014,GNRL,214273522
64654,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,84.01,03/04/2014,GNRL,149242042
64654,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,84.00,09/17/2014,GNRL,150770370
64654,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,83.90,06/18/2015,GNRL,290539148
64654,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,83.48,08/12/2014,GNRL,148444620
64654,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,83.20,07/29/2015,GNRL,318765814
64654,GNRL,"TEI Medical Inc.",MA,100000071385,82.51,11/17/2014,GNRL,214273520
64654,GNRL,"Actelion Pharmaceuticals US, Inc.",CA,100000010813,82.00,03/19/2014,GNRL,194994194
64654,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,80.42,10/21/2014,GNRL,150905294
64654,GNRL,"Celgene Corporation",NJ,100000000343,80.01,04/09/2014,GNRL,189920104
64654,GNRL,"LifeCell Corporation",NJ,100000010566,80.00,11/09/2013,GNRL,178714106
64654,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,79.64,06/17/2014,GNRL,155747596
64654,GNRL,"Actelion Pharmaceuticals US, Inc.",CA,100000010813,79.47,03/19/2015,GNRL,326574048
64654,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,79.38,10/30/2013,GNRL,13971299
64654,GNRL,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,78.97,08/04/2015,GNRL,321565190
64654,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,78.75,11/12/2014,GNRL,149889906
64654,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,78.75,08/07/2014,GNRL,155747604
64654,GNRL,"Amgen Inc.",CA,100000000203,77.88,07/15/2015,GNRL,297198534
64654,GNRL,"Pfizer Inc.",NY,100000000286,77.77,09/07/2013,GNRL,206062132
64654,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,76.19,08/26/2015,GNRL,319733412
64654,GNRL,"AngioDynamics, Inc.",NY,100000005504,76.10,09/20/2013,GNRL,31850860
64654,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,75.93,09/04/2014,GNRL,148322082
64654,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,74.69,03/25/2015,GNRL,255800754
64654,GNRL,"Derma Sciences, Inc.",NJ,100000010786,74.50,01/13/2015,GNRL,324405438
64654,GNRL,"Cook Incorporated",IN,100000010458,74.00,07/07/2014,GNRL,211329272
64654,GNRL,"MedImmune, LLC",MD,100000000169,73.14,03/11/2014,GNRL,150474988
64654,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,73.00,11/19/2014,GNRL,155747606
64654,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,72.49,06/11/2015,GNRL,318730171
64654,GNRL,"Organogenesis Inc.",MA,100000011175,72.33,12/05/2013,GNRL,317546932
64654,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,72.13,12/04/2013,GNRL,23817236
64654,GNRL,"Lantheus Medical Imaging, Inc.",MA,100000005400,71.65,08/22/2013,GNRL,101634012
64654,GNRL,"LifeCell Corporation",NJ,100000010566,69.09,01/20/2014,GNRL,188323240
64654,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,67.38,06/24/2014,GNRL,148857674
64654,GNRL,"Derma Sciences, Inc.",NJ,100000010786,67.34,01/20/2015,GNRL,324405450
64654,GNRL,"Bard Peripheral Vascular, Inc.",AZ,100000005481,67.25,02/27/2014,GNRL,215131674
64654,GNRL,"Cook Incorporated",IN,100000010458,65.12,08/18/2014,GNRL,211348100
64654,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,64.59,07/28/2014,GNRL,187988536
64654,GNRL,"Amgen Inc.",CA,100000000203,63.98,09/21/2015,GNRL,297198540
64654,GNRL,"Bard Peripheral Vascular, Inc.",AZ,100000005481,63.07,04/29/2015,GNRL,317647316
64654,GNRL,"Amgen Inc.",CA,100000000203,62.14,08/17/2015,GNRL,297198536
64654,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,60.70,04/13/2015,GNRL,319308975
64654,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,60.65,08/21/2013,GNRL,23817235
64654,GNRL,"Organogenesis Inc.",MA,100000011175,60.46,08/26/2013,GNRL,105407532
64654,GNRL,"Amgen Inc.",CA,100000000203,59.96,09/28/2015,GNRL,297198548
64654,GNRL,"Smith & Nephew, Inc.",TN,100000005456,59.21,03/09/2015,GNRL,303055098
64654,GNRL,"Cook Incorporated",IN,100000010458,55.95,06/08/2014,GNRL,211348092
64654,GNRL,"Covidien Sales LLC",MA,100000000098,55.59,05/18/2014,GNRL,221971634
64654,GNRL,"Pfizer Inc.",NY,100000000286,54.67,08/09/2013,GNRL,205606008
64654,GNRL,"W. L. Gore & Associates, Inc.",DE,100000010774,54.00,10/22/2013,GNRL,30615556
64654,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,53.16,01/12/2015,GNRL,332314439
64654,GNRL,"Gilead Sciences Inc",CA,100000000108,51.63,11/03/2014,GNRL,168246614
64654,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,51.36,05/04/2015,GNRL,332425251
64654,GNRL,"LifeCell Corporation",NJ,100000010566,50.00,11/09/2013,GNRL,178714104
64654,GNRL,"Novo Nordisk Inc",NJ,100000000144,49.63,12/16/2014,GNRL,162386378
64654,GNRL,"Medtronic Vascular, Inc.",MN,100000010384,49.61,03/30/2015,GNRL,296160114
64654,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,49.02,04/07/2015,GNRL,256309251
64654,GNRL,"TEI Medical Inc.",MA,100000071385,48.00,10/13/2014,GNRL,214273517
64654,GNRL,"Organogenesis Inc.",MA,100000011175,47.14,01/23/2014,GNRL,222248136
64654,GNRL,"Janssen Scientific Affairs, LLC",NJ,100000000332,45.86,08/27/2014,GNRL,155747610
64654,GNRL,"The Spectranetics Corporation",CO,100000005380,45.36,07/14/2014,GNRL,204833762
64654,GNRL,"Covidien Sales LLC",MA,100000000098,43.42,05/27/2014,GNRL,222076534
64654,GNRL,"Organogenesis Inc.",MA,100000011175,43.28,10/23/2013,GNRL,105407416
64654,GNRL,"Organogenesis Inc.",MA,100000011175,43.28,10/23/2014,GNRL,222248138
64654,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,43.21,03/30/2015,GNRL,290539144
64654,GNRL,"LifeCell Corporation",NJ,100000010566,42.74,11/14/2013,GNRL,178711356
64654,GNRL,"The Spectranetics Corporation",CO,100000005380,42.73,10/20/2014,GNRL,204833764
64654,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,40.40,03/09/2015,GNRL,274767854
64654,GNRL,"KCI USA, Inc",TX,100000010396,39.33,11/12/2014,GNRL,198875618
64654,GNRL,"Covidien Sales LLC",MA,100000000098,39.00,07/01/2014,GNRL,222076530
64654,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,37.71,07/30/2014,GNRL,150047924
64654,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,37.45,02/06/2015,GNRL,256282376
64654,GNRL,"Organogenesis Inc.",MA,100000011175,36.69,06/18/2015,GNRL,308853764
64654,GNRL,"Bard Peripheral Vascular, Inc.",AZ,100000005481,36.24,12/15/2014,GNRL,215170096
64654,GNRL,"KCI USA, Inc",TX,100000010396,35.00,09/30/2014,GNRL,198888988
64654,GNRL,"Access Closure, Inc",OH,100000010722,34.90,09/03/2014,GNRL,152711998
64654,GNRL,"LifeCell Corporation",NJ,100000010566,34.37,11/08/2013,GNRL,178709812
64654,GNRL,"Organogenesis Inc.",MA,100000011175,33.33,10/23/2013,GNRL,105407376
64654,GNRL,"Organogenesis Inc.",MA,100000011175,33.33,10/23/2014,GNRL,222248140
64654,GNRL,"W. L. Gore & Associates, Inc.",DE,100000010774,32.96,12/10/2015,GNRL,295980578
64654,GNRL,"Organogenesis Inc.",MA,100000011175,31.70,11/30/2013,GNRL,105407354
64654,GNRL,"Organogenesis Inc.",MA,100000011175,31.70,11/30/2013,GNRL,105407352
64654,GNRL,"Organogenesis Inc.",MA,100000011175,31.70,12/11/2014,GNRL,222248146
64654,GNRL,"Organogenesis Inc.",MA,100000011175,31.69,11/30/2013,GNRL,105407350
64654,GNRL,"Organogenesis Inc.",MA,100000011175,31.69,11/30/2013,GNRL,105407348
64654,GNRL,"Organogenesis Inc.",MA,100000011175,31.41,10/22/2013,GNRL,105407344
64654,GNRL,"Bard Peripheral Vascular, Inc.",AZ,100000005481,29.09,08/05/2013,GNRL,101616706
64654,GNRL,"Cardiovascular Systems Inc.",MN,100000000117,27.50,06/26/2014,GNRL,204299574
64654,GNRL,"Cook Incorporated",IN,100000010458,27.37,05/08/2014,GNRL,211348090
64654,GNRL,"Organogenesis Inc.",MA,100000011175,26.60,04/17/2015,GNRL,308853759
64654,GNRL,"Cordis Corporation",CA,100000005411,26.28,06/19/2014,GNRL,120479631
64654,GNRL,"Bard Peripheral Vascular, Inc.",AZ,100000005481,26.28,05/12/2014,GNRL,215142288
64654,GNRL,"Covidien Sales LLC",MA,100000000098,26.16,10/20/2014,GNRL,222076524
64654,GNRL,"TEI Medical Inc.",MA,100000071385,25.67,12/01/2014,GNRL,214273514
64654,GNRL,"Derma Sciences, Inc.",NJ,100000010786,24.79,02/13/2015,GNRL,324405214
64654,GNRL,"Bard Peripheral Vascular, Inc.",AZ,100000005481,24.60,04/09/2015,GNRL,317645466
64654,GNRL,"Cook Incorporated",IN,100000010458,24.53,06/27/2014,GNRL,211348096
64654,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,24.43,02/18/2014,GNRL,149742604
64654,GNRL,"Bard Peripheral Vascular, Inc.",AZ,100000005481,23.42,10/14/2013,GNRL,101620618
64654,GNRL,"WARDLOW ENTERPRISES",IA,100000010546,23.01,05/14/2014,GNRL,153916092
64654,GNRL,"Bard Peripheral Vascular, Inc.",AZ,100000005481,22.73,01/29/2015,GNRL,317638600
64654,GNRL,"Cardiovascular Systems Inc.",MN,100000000117,20.92,07/21/2014,GNRL,204284134
64654,GNRL,"Cook Incorporated",IN,100000010458,20.30,06/10/2014,GNRL,211348094
64654,GNRL,"Medtronic Vascular, Inc.",MN,100000010384,19.51,08/04/2015,GNRL,296902650
64654,GNRL,"Cardiovascular Systems Inc.",MN,100000000117,18.51,03/19/2015,GNRL,318329384
64654,GNRL,"Cook Incorporated",IN,100000010458,18.18,11/18/2014,GNRL,211348102
64654,GNRL,"Bard Peripheral Vascular, Inc.",AZ,100000005481,18.04,03/13/2015,GNRL,317643270
64654,GNRL,"AngioDynamics, Inc.",NY,100000005504,17.34,09/17/2014,GNRL,192795808
64654,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,17.11,01/07/2015,GNRL,331497343
64654,GNRL,"Cordis Corporation",CA,100000005411,16.04,06/11/2014,GNRL,120479633
64654,GNRL,"Derma Sciences, Inc.",NJ,100000010786,15.94,10/29/2014,GNRL,179641832
64654,GNRL,"Organogenesis Inc.",MA,100000011175,15.93,12/05/2013,GNRL,317546934
64654,GNRL,"Bard Peripheral Vascular, Inc.",AZ,100000005481,15.80,01/16/2014,GNRL,215126534
64654,GNRL,"Cook Incorporated",IN,100000010458,14.99,07/07/2014,GNRL,211328232
64654,GNRL,"Bard Peripheral Vascular, Inc.",AZ,100000005481,14.84,04/24/2015,GNRL,317646998
64654,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,14.14,11/05/2014,GNRL,155747608
64654,GNRL,"Organogenesis Inc.",MA,100000011175,13.65,01/30/2015,GNRL,308853752
64654,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,13.33,09/21/2015,GNRL,331974671
64654,GNRL,"Organogenesis Inc.",MA,100000011175,13.04,10/23/2013,GNRL,105407140
64654,GNRL,"KCI USA, Inc",TX,100000010396,12.98,09/30/2013,GNRL,103396642
64654,GNRL,"Bard Peripheral Vascular, Inc.",AZ,100000005481,12.94,07/15/2014,GNRL,215150750
64654,GNRL,"Smith & Nephew, Inc.",TN,100000005456,12.65,05/28/2014,GNRL,182956170
64654,GNRL,"The Spectranetics Corporation",CO,100000005380,12.06,04/24/2014,GNRL,204833760
64654,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,11.72,06/30/2014,GNRL,155747602
64654,GNRL,"Access Closure, Inc",OH,100000010722,10.95,11/12/2014,GNRL,152712330
64654,GNRL,"Bard Peripheral Vascular, Inc.",AZ,100000005481,10.89,01/03/2014,GNRL,215126054
64654,GNRL,"Organogenesis Inc.",MA,100000011175,9.09,01/23/2014,GNRL,222248144
64654,GNRL,"TEI Medical Inc.",MA,100000071385,8.83,03/31/2014,GNRL,214273508
64654,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,8.82,11/12/2013,GNRL,100728628
64654,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,8.30,01/27/2014,GNRL,155747592
64654,GNRL,"Bard Peripheral Vascular, Inc.",AZ,100000005481,7.09,02/27/2014,GNRL,215131822
64654,GNRL,"Bard Peripheral Vascular, Inc.",AZ,100000005481,3.25,11/11/2014,GNRL,215166624
64654,GNRL,"Bard Peripheral Vascular, Inc.",AZ,100000005481,2.65,05/28/2014,GNRL,215145524
64654,GNRL,"Pfizer Inc.",NY,100000000286,0.65,01/30/2015,GNRL,322432236
